CA2241935A1 - Tea, kit and method for treating hemorrhoids - Google Patents
Tea, kit and method for treating hemorrhoids Download PDFInfo
- Publication number
- CA2241935A1 CA2241935A1 CA002241935A CA2241935A CA2241935A1 CA 2241935 A1 CA2241935 A1 CA 2241935A1 CA 002241935 A CA002241935 A CA 002241935A CA 2241935 A CA2241935 A CA 2241935A CA 2241935 A1 CA2241935 A1 CA 2241935A1
- Authority
- CA
- Canada
- Prior art keywords
- equisetum
- forma
- composition
- herb
- arvense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Abstract
An anti-hemorrhoidal composition, tea, and kit containing tea bags including, in combination, a first herb of the genus Equisetaceae and a second herb of the Generie Juliania, family Julianiaceae, genus amphipterygium adstringens (also known as "Cuachalalate") is provided herein. Further provided herein is a method of treating hemorrhoids and a method for making an anti-hemorrhoidal composition.
Description
TE~. KlT AND METHOD FO~ TREATING HEMORRHOIDS
This invention relates to a treatment for hemorrhoids and symptoms thereof;
and, more particularly, it relates to a composition of matter, tea, kit and ~ for the condition of h~,u.or.l~oids.
BACKG~OUND OF THE ~VENTIO~
S Various Aice~ses of the anorectal region of the human body are cl-~a-;~el~d by infi~m m~t~on, itching, and ulcerations. The anorectal region is generally comprised of the anus, rectum, and lower colon. ~n particular, hemorrhoids or piles are a common ailment of the anorectal region, and may be intemally or e~ternallylocated in the anorectal area. Notwithct~nAing their location, veins in the ano-~cLal 10 area become inft~n~e~l and frequently result in itching. The causes of hemorrhoids include pre~ ;..g causes such as erect posture, heredity, oc~ p~;Qn and diet, constipation, ~i~rrh~, pre~lan.,y, anal infection, pelvic tumors, rectal carçin()~
cardiac failure, portal hypertension, ~,u--liLhLg and physical exertion.
Many ren~ s are known for the alleviation of these ~ ptoms. Most of the 15 rem~lies in the art have varying degrees of su~cçcs~ and few re neAie5 have been :~. rccs~rul in substantially rerl~lcin~ or completely etimin~ting hemorrhoidal ~yllllJtOlllS
without undesirable side effects.
That is, there are undesirable side effects of these known trç~tm~onrs. lt is these undesirable side effects of these treatments that fre~uently prevent users of these 20 treatments from ob~ ihlg ~APqll~tç relief. Hence, there e~cists a need for a llc~ e.~
for hemorrhoids that s-~ t;~lly or completely eli...;. ~'~s hemorrhoids, while being free of undesirable side effects ~ori~teA with the tre~tmçnt The prior art has sl-g~esteA the therapeutic utility of certain unknown co.l.~ou.lds of various herbs. In particular, U.S. Patent hio. 481.81; to Page et al 25 describes a her~al composition C~ -;c~.A of ~cacia Farnesiana, Acacia constricta, an~ F~or~rensia Cornua; U.S. Patent ~o. ~27~.138 to Holder discloses an ointrnent comprising Anlhemis cotula; U S. Patent ~o. 3,781,42~ to Po"~e" tlicclosps a composition cc~lu~iaing extracts~of ~-n~ m annum; U.S. Patent No. 1,383,896 to Wood et al. discloses an ointme~t co~ h,il,g t~lra~LS of Gnapha~ium, Balm of C;~ead buds, and elder bar~; U.S. Patent No. 1,890,596 to Zographos rti~lo~s an ointm~rlt COlll~liSillg e~LIa~, of powdered calomel and green tansy weed; U.S. Patent No.
3,93~,310 to Homan discloses a Co-"~silion col~lp~ g e:macts of Ce~asm s scandens; U.S. Patent No. 4,761,285 to Vasiliou et al. rlic~loses a ccsl~o~itionCG~ lisillg extracts of Leptandra root, chick peas and grape seeds, U.S. Patent No.
3,464,972 to Rocher discloses a composition colllyli,illg extracts of ~icaria ranunculus; and, U.S. Patent No. ~,007,767 to Masse rticrlnseS a co.l-~osi~ion 10 coul~lisillg extracts of the ~s~coao fami~y. Yet none of these co-l.~osiLions involve the use of the combination of the herbs dcsc.ibed in the present invention.
Further, the tre~tmPnt of hemorrhoids is comrliG~t~Prt by the fact ~hat during defec~tion, the fecal mass :,--G~,Les, tears and irr~tates the already infl~me~l and swollen hemorrhoidal tissue. Further, as a result of ~t1rti~ir~n~l muscle strain during 15 rlefer~t;on resu1tin~ from the physical movement of the fecal mass through the a}ready swollen and infl~m~rt tissue, he~ io~ of the anal walls frequently results.
Moreover, the e~c.c~,.y tract is the site of numerous or~nicmc that are infectious and that enjoy infiltrating the anal cavity herniations. This ir~lltration further damages already ~t~m~Prl tissue and agg.a~ es the hPs-lin~ process. If left untreated 20 hemorrhoids often worsen and re~uire ~.Uly,GIy to remove the rtiCeZ-CPr~ hemorrhoidal tissue.
Tre~tm~nt~, of h~.--o-~l~oids have tended to focus on topical ~rpiir~tjons of creams and iotions and suppositories having ",rrt;r .",Pn~c therein that have sought to relieve itc'ning (Pruritis ani) andior infl~mm~tir~n The eff~cacy of the prior art ;~ tre~rrnerts in relieving or curing a variety of symptoms is ~ c,Lain. Exemplarv such creams or lotions are described in: U.S. Patent No. 4,169,143 to Haimowitz whichrlic~ losPs a hcahllcnt of hemorrhoids ~,vith compositions CO~ isillg Vi~amin E; U.S
Patent ~io. 3,067.716 to Montandraud which disclases a l~aL~I~ellt of hemorrhoids W O 97/25997 PCT~US97/00428 with compositions comprising heparin; U.S. Patent No. 3,534,102 to Waldstein which discloses a treatment of hemorrhoids with compositions comprising reaction products of elemental iodine and alkoxylated alkylarnine ox~des; I~.S. Patent l~io. 3,~94,473 to Hunger et al. which discloses a tr~o~fment of hemorrhoids with colll~;L;~
S co~ ising reaction productc of ethyl-3,5,6-tri-O-benzvl-D-glucofuranoside; U.S.
Patent No. 5, ~66,571 to Amer lli~lc ses a treat~t of hemorrhoids with 5-hyd.u~yl,y},tauline antagonist; U.S. Patent No. 4,945,08~ to P~cl~m~n discloses a treatment of hemorrhoids with ~iic~rrh~ polysulfate-alnmint-m compounds; I,'.S.
Patent No. 4,~18,480 to Williams rlicrloses a treatment of hemorrhoids with a mimlre of c~ ~ul~ds; U.S. Patent No. 4,202,825 to Taya riiccloses a tre~nnent of hemorrhoids with a de.ivalive of ~u. l~,clhl; U.S. Patent l~o. 4,26~,887 to Breskman discloses a tre~nrrlt of hemorrhoids with a l~ e of viL~ s; U.S. Patent No.
4,676,433 to Gold ~licrloses a tre~ttnrrlt of hemorrhoids with a salve . ol~ ingallJ..~;,.~..,. pot; ~ sulfate, linseed oil, methanol, c ~ ..rhr,r and pure petroleum jelly;
1~ U.S. Patent No. 4,985,757 to Verde Aicrloses a llc~ t of hemorrhoids with aco~ o~ ion co...~ ;ng cream of tartar; U.S. Patent No. 5,196,405 to Oakman discloses a tr~ nent of hemorrhoids with a colll~osilion CGll~ hlg rlic~crh~Tide poly-sulfate-~ minl~rn colll~oullds; U.S. Patent No. 5.734,914 to Gallina ~iccc~oses a h~ ..el.t of hemorrhoids with a composition comprising hyaluronic acid; and, IJ.S
Patent No. 5,403,867 to Okumura discloses a treatment of hemorrhoids with a colll~o~ilion having dll~i~luliLiC ~lupclLics. However, all of the topical ylcl)alaLions have the drawback or further ~2~i~tin~ already swollen and inf~m~fi tissue by the manual application of the m~ c~mr~tt ~urther, there may be hemorrhoids loca~ed deep within the anal rectal cavity that are in~rC-occible from the exterior thereof for 7~ the topical application of mrrlir~mPnt~ Hence, there e~ists a need for an edible composition that can be taken orally ~or the relief and treatment of intemal ~ hemorrhoids and hemorrhoidal sy~ ullls~ It is an object of ~he present invention to solve the problems in the art.
t W O 97/25997 PCTrUS97/00428 ~ilJMMA,RY OF 'I ~; INVEI~ION
It is a further object of the present invention to provide a low cost, effectivecure for the treatment of hemorrhoids with no side effects. An anti-hemorrhoidalrc,l,.~sll;on, tea, and kit cont~in;n~ tea bags including, in combination, a first herb of the genus FqUisptncp~e and a second herb of the farnily Julianiaceae, genus amphiptt~ siu~" adstring~ens is provided herein. The herb from the genus Fq~/icetacene is selected from the group concic~in~ of ~orse~l. Flz~ispn/1r~ arvense, Fq~ic~pn/~n hyemale, Fqr~isPr~ n fZuviatile, FqyiSpn~ kar,sun~r/l, Fq~lisPn~m litorale, Fqr(icPn~tnpalustre, F~r~iS~Pt~mpratense, F;7r~jspn/mscirpoides, F;~t~icPt~msy~vaticum, 10 Fq~;s~pn~tn7 Telemateia, Equisetum variegatum, E;~uisetum de~ile, F~icen/~tz e~ongatum, Fq~icet~~n gigan~eum, and Frr~/ic~Pn/m m~ ~.r,.,.". The herb from thegenus F1~icetr~m arvense is s~l~-cte~l from the group con~ictin~ Gf Fq~icPn/m arvenSe var. boreale, F1~/icet1~m arvense forrna alpestre, F~r~/iser~m arvense forma ca".~C~Ir~, Fqr~jsetl/tn arvense forma ~ , F~ e17~1n arvense fo~rna pseu~lo-alpestre~
15 F1uic~Pt~n arvense forrnapseudo-silvaticum, Fqr~isPt7~n arvense forrnapseudo-varium, Fqr/icPtr~tn arvense forrna ramulosum, and Fq~ic,Pn~m arvense ~orma vaAum Optionally, the herb, FqrrisPn~m hyemale, is selected from the group c~ g of Fqr/icen~m hyemale var. affine, Fqr~icel7~m *yemale var. intermedium, Fqujcet1~
hyemale var. m~stum, Fq!~icet~/m hyemale forma polystachyum, Fq~/icptr/m hyemale20 forma proliferrlm, a~d Fq1~jsen~m hyemale forma pumilum, the herb, Fquic~n~n palustre, is sel~ctecl from the group co..~;c~ of FquicPf~/tn palustre fonna arcuatum, Fq1/icPt1~m palustre forma fi~iforme, Fq1~icPn~tn palustre forma fluitanc, Fq1ricen~m palustre forrnanigridens, Fq~/icetr/m palustre formapolystachion, Fqr~iset1~n palustre forma rnm1~1Os~n, Fq~icet~m palustre forma vertici~ntr~tn, and Fqr~isetr~rn palusn~e 75 forma simplex, and the herb~ F~/jSf~n/tn TP1Pmateia, is sf lect~cl from the group con~i~ting of Equisetum Telemateia var. pauciramosum, and Fquic~t~/1n Telemate~aforma mul~i,u"",.osum The second herb of the family Julianiaceae, genus amp~ipterygium adstringen~s is selected from the group con~i~tinsg of c~l~rh~ t~
CA 0224193~ 1998-06-29 W O 97/25997 PCTrUS97100428 The method of manufacturing an anti-hemorrhoidal composition includes the steps of ~1mixing an effective amount of a first herb of the genus F1~;sernc~e and an effective amount of a second herb of the family Julianiaceae, genus amphiprerygium adstrin~ens with a solvent to obtain a herbal mixture. The herbal mixture is heated for an effective time period to obtain a prepared herbal mixture. Preferably, the solvent is water. Optionally, the method includes the step of steeping the prepared herbal mixture to obtain a steeped herbal mixture and sifting the steeped herbal mixture to obtain a substantially purified herbal tea. Optionally, the antihemorrhoidal composition is packaged. p~k:~ing includes a tea bag, a capsule. a tablet. a concentrated liquid. and a powdered mixture. Preferably, the first herb and the second herb are separately pulverized in a blender and then mixed in a volume ratio of 1 to 1. Similarly, such a pulverizahon will generally result in a weight ratio of first herb to second herb of one to two. ~3y way of example, the first herb is half as heavy as the second herb.
The method of treating hemorrhoids provided herein includes the step of periodically ingesting a thelal.e~lically effective amount of the composition descrihed above. It is a further object of the present invention to solve the problems articulaled in the background section of the invention. The obiects and features of the present invention, other than those specifically set forth above. wi~l become apparent in the detailed description of the invention set forth below.
Bl~FF I)ESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of the kit of the presen~ invention.
SUBSTiTUTE SHEET (RULE 26) W O 97/25997 PCT~US97/00428 D'E~AILED DESCRI~ON OF THE INVENTION
The invention is based upon the discovery that ingestion of a processed composition of maner of a first her~ of the genus Fq~ etncpne and a second herb of the Generie Ju~ian a, family Julzanzaceae, genus ~",~,J~t~"~gzum ads~ingens (also known as l'C'~ h-AlAl-At~") as active ingredients relieves helllorllloidal ~ylll~tullls and reduces the swelling of hemorrhoids. Periodic ;ng~stion of a l11elAI~ ..r;~--Ally effective amount of this ~~ollllJo:,ition relieves hemorrhoidal symptoms within a short period of time.
T~e herb of the genus F~ ptncpne is selected from the group concict;ng of 10 Horsetail (also known as "~.~n~ llo"), F1rri~e~rl-7z nrvense (also known as "Corn Horsetail" and "Field Horsetail"), Fyr~isptr~m hyemale (also known as "Common Scouring Rush"), Fqr~i~et~r~m fiuvzat.ile, Fq~ en~m ~";"~ "., F~ Ptr~rn li~orale, Fqr~isetrlrn palustre~ Fqr~i~et~ "ul~"se~ Fqr~i~Ptr~m scirpoides (~so known as "Dwarf Scouring Rush"), F~ ptr~m sylvaticum {also known as ~Wood Horsetail~'), Fqr~ice~~m 7tPmAtpin~ Fqrli~pn~m variegatum (also known as "~ariegated Rush"), FAltri~et debile, F~irr~ Pn~rn elQngA~ n, Fqui~P~m gi~ c~ and Fqr/i~m~n m~ ~1".~
Fqr/i~et;.~m arvense (also known as "Great River ~Iorsetail" in one variant) is selected from the group con~;cl;--s~ of Fqr~ Ptr~qt arvense var. boreale, Fq~r/i~eh~m arvense forma alpestre, Fqu jsPtr/m arvense forma c, ".yc~/re, Fquiset~m arvense forma 20 diffusum, Fqr~i~etr~rr. arvense forrnapseudo-alpestre, Fq~ic~r.~m arvense formapseudo-silva~icum, Fq~ etr~m arvense forma pseudo-vari~m, F~i~err~m arvense forma r~ rr~ sr~m, and F~lr~iseh~ ,"e forma varium.
Fqujsetr~tn hyemale is selected from the group CQncictin~ of Fquic~trr~l hyemalevar. affine (also known as "Fyuic.~ l Prealtum"). Fq~/icetr/m hyemale var.
This invention relates to a treatment for hemorrhoids and symptoms thereof;
and, more particularly, it relates to a composition of matter, tea, kit and ~ for the condition of h~,u.or.l~oids.
BACKG~OUND OF THE ~VENTIO~
S Various Aice~ses of the anorectal region of the human body are cl-~a-;~el~d by infi~m m~t~on, itching, and ulcerations. The anorectal region is generally comprised of the anus, rectum, and lower colon. ~n particular, hemorrhoids or piles are a common ailment of the anorectal region, and may be intemally or e~ternallylocated in the anorectal area. Notwithct~nAing their location, veins in the ano-~cLal 10 area become inft~n~e~l and frequently result in itching. The causes of hemorrhoids include pre~ ;..g causes such as erect posture, heredity, oc~ p~;Qn and diet, constipation, ~i~rrh~, pre~lan.,y, anal infection, pelvic tumors, rectal carçin()~
cardiac failure, portal hypertension, ~,u--liLhLg and physical exertion.
Many ren~ s are known for the alleviation of these ~ ptoms. Most of the 15 rem~lies in the art have varying degrees of su~cçcs~ and few re neAie5 have been :~. rccs~rul in substantially rerl~lcin~ or completely etimin~ting hemorrhoidal ~yllllJtOlllS
without undesirable side effects.
That is, there are undesirable side effects of these known trç~tm~onrs. lt is these undesirable side effects of these treatments that fre~uently prevent users of these 20 treatments from ob~ ihlg ~APqll~tç relief. Hence, there e~cists a need for a llc~ e.~
for hemorrhoids that s-~ t;~lly or completely eli...;. ~'~s hemorrhoids, while being free of undesirable side effects ~ori~teA with the tre~tmçnt The prior art has sl-g~esteA the therapeutic utility of certain unknown co.l.~ou.lds of various herbs. In particular, U.S. Patent hio. 481.81; to Page et al 25 describes a her~al composition C~ -;c~.A of ~cacia Farnesiana, Acacia constricta, an~ F~or~rensia Cornua; U.S. Patent ~o. ~27~.138 to Holder discloses an ointrnent comprising Anlhemis cotula; U S. Patent ~o. 3,781,42~ to Po"~e" tlicclosps a composition cc~lu~iaing extracts~of ~-n~ m annum; U.S. Patent No. 1,383,896 to Wood et al. discloses an ointme~t co~ h,il,g t~lra~LS of Gnapha~ium, Balm of C;~ead buds, and elder bar~; U.S. Patent No. 1,890,596 to Zographos rti~lo~s an ointm~rlt COlll~liSillg e~LIa~, of powdered calomel and green tansy weed; U.S. Patent No.
3,93~,310 to Homan discloses a Co-"~silion col~lp~ g e:macts of Ce~asm s scandens; U.S. Patent No. 4,761,285 to Vasiliou et al. rlic~loses a ccsl~o~itionCG~ lisillg extracts of Leptandra root, chick peas and grape seeds, U.S. Patent No.
3,464,972 to Rocher discloses a composition colllyli,illg extracts of ~icaria ranunculus; and, U.S. Patent No. ~,007,767 to Masse rticrlnseS a co.l-~osi~ion 10 coul~lisillg extracts of the ~s~coao fami~y. Yet none of these co-l.~osiLions involve the use of the combination of the herbs dcsc.ibed in the present invention.
Further, the tre~tmPnt of hemorrhoids is comrliG~t~Prt by the fact ~hat during defec~tion, the fecal mass :,--G~,Les, tears and irr~tates the already infl~me~l and swollen hemorrhoidal tissue. Further, as a result of ~t1rti~ir~n~l muscle strain during 15 rlefer~t;on resu1tin~ from the physical movement of the fecal mass through the a}ready swollen and infl~m~rt tissue, he~ io~ of the anal walls frequently results.
Moreover, the e~c.c~,.y tract is the site of numerous or~nicmc that are infectious and that enjoy infiltrating the anal cavity herniations. This ir~lltration further damages already ~t~m~Prl tissue and agg.a~ es the hPs-lin~ process. If left untreated 20 hemorrhoids often worsen and re~uire ~.Uly,GIy to remove the rtiCeZ-CPr~ hemorrhoidal tissue.
Tre~tm~nt~, of h~.--o-~l~oids have tended to focus on topical ~rpiir~tjons of creams and iotions and suppositories having ",rrt;r .",Pn~c therein that have sought to relieve itc'ning (Pruritis ani) andior infl~mm~tir~n The eff~cacy of the prior art ;~ tre~rrnerts in relieving or curing a variety of symptoms is ~ c,Lain. Exemplarv such creams or lotions are described in: U.S. Patent No. 4,169,143 to Haimowitz whichrlic~ losPs a hcahllcnt of hemorrhoids ~,vith compositions CO~ isillg Vi~amin E; U.S
Patent ~io. 3,067.716 to Montandraud which disclases a l~aL~I~ellt of hemorrhoids W O 97/25997 PCT~US97/00428 with compositions comprising heparin; U.S. Patent No. 3,534,102 to Waldstein which discloses a treatment of hemorrhoids with compositions comprising reaction products of elemental iodine and alkoxylated alkylarnine ox~des; I~.S. Patent l~io. 3,~94,473 to Hunger et al. which discloses a tr~o~fment of hemorrhoids with colll~;L;~
S co~ ising reaction productc of ethyl-3,5,6-tri-O-benzvl-D-glucofuranoside; U.S.
Patent No. 5, ~66,571 to Amer lli~lc ses a treat~t of hemorrhoids with 5-hyd.u~yl,y},tauline antagonist; U.S. Patent No. 4,945,08~ to P~cl~m~n discloses a treatment of hemorrhoids with ~iic~rrh~ polysulfate-alnmint-m compounds; I,'.S.
Patent No. 4,~18,480 to Williams rlicrloses a treatment of hemorrhoids with a mimlre of c~ ~ul~ds; U.S. Patent No. 4,202,825 to Taya riiccloses a tre~nnent of hemorrhoids with a de.ivalive of ~u. l~,clhl; U.S. Patent l~o. 4,26~,887 to Breskman discloses a tre~nrrlt of hemorrhoids with a l~ e of viL~ s; U.S. Patent No.
4,676,433 to Gold ~licrloses a tre~ttnrrlt of hemorrhoids with a salve . ol~ ingallJ..~;,.~..,. pot; ~ sulfate, linseed oil, methanol, c ~ ..rhr,r and pure petroleum jelly;
1~ U.S. Patent No. 4,985,757 to Verde Aicrloses a llc~ t of hemorrhoids with aco~ o~ ion co...~ ;ng cream of tartar; U.S. Patent No. 5,196,405 to Oakman discloses a tr~ nent of hemorrhoids with a colll~osilion CGll~ hlg rlic~crh~Tide poly-sulfate-~ minl~rn colll~oullds; U.S. Patent No. 5.734,914 to Gallina ~iccc~oses a h~ ..el.t of hemorrhoids with a composition comprising hyaluronic acid; and, IJ.S
Patent No. 5,403,867 to Okumura discloses a treatment of hemorrhoids with a colll~o~ilion having dll~i~luliLiC ~lupclLics. However, all of the topical ylcl)alaLions have the drawback or further ~2~i~tin~ already swollen and inf~m~fi tissue by the manual application of the m~ c~mr~tt ~urther, there may be hemorrhoids loca~ed deep within the anal rectal cavity that are in~rC-occible from the exterior thereof for 7~ the topical application of mrrlir~mPnt~ Hence, there e~ists a need for an edible composition that can be taken orally ~or the relief and treatment of intemal ~ hemorrhoids and hemorrhoidal sy~ ullls~ It is an object of ~he present invention to solve the problems in the art.
t W O 97/25997 PCTrUS97/00428 ~ilJMMA,RY OF 'I ~; INVEI~ION
It is a further object of the present invention to provide a low cost, effectivecure for the treatment of hemorrhoids with no side effects. An anti-hemorrhoidalrc,l,.~sll;on, tea, and kit cont~in;n~ tea bags including, in combination, a first herb of the genus FqUisptncp~e and a second herb of the farnily Julianiaceae, genus amphiptt~ siu~" adstring~ens is provided herein. The herb from the genus Fq~/icetacene is selected from the group concic~in~ of ~orse~l. Flz~ispn/1r~ arvense, Fq~ic~pn/~n hyemale, Fqr~isPr~ n fZuviatile, FqyiSpn~ kar,sun~r/l, Fq~lisPn~m litorale, Fqr(icPn~tnpalustre, F~r~iS~Pt~mpratense, F;7r~jspn/mscirpoides, F;~t~icPt~msy~vaticum, 10 Fq~;s~pn~tn7 Telemateia, Equisetum variegatum, E;~uisetum de~ile, F~icen/~tz e~ongatum, Fq~icet~~n gigan~eum, and Frr~/ic~Pn/m m~ ~.r,.,.". The herb from thegenus F1~icetr~m arvense is s~l~-cte~l from the group con~ictin~ Gf Fq~icPn/m arvenSe var. boreale, F1~/icet1~m arvense forrna alpestre, F~r~/iser~m arvense forma ca".~C~Ir~, Fqr~jsetl/tn arvense forma ~ , F~ e17~1n arvense fo~rna pseu~lo-alpestre~
15 F1uic~Pt~n arvense forrnapseudo-silvaticum, Fqr~isPt7~n arvense forrnapseudo-varium, Fqr/icPtr~tn arvense forrna ramulosum, and Fq~ic,Pn~m arvense ~orma vaAum Optionally, the herb, FqrrisPn~m hyemale, is selected from the group c~ g of Fqr/icen~m hyemale var. affine, Fqr~icel7~m *yemale var. intermedium, Fqujcet1~
hyemale var. m~stum, Fq!~icet~/m hyemale forma polystachyum, Fq~/icptr/m hyemale20 forma proliferrlm, a~d Fq1~jsen~m hyemale forma pumilum, the herb, Fquic~n~n palustre, is sel~ctecl from the group co..~;c~ of FquicPf~/tn palustre fonna arcuatum, Fq1/icPt1~m palustre forma fi~iforme, Fq1~icPn~tn palustre forma fluitanc, Fq1ricen~m palustre forrnanigridens, Fq~/icetr/m palustre formapolystachion, Fqr~iset1~n palustre forma rnm1~1Os~n, Fq~icet~m palustre forma vertici~ntr~tn, and Fqr~isetr~rn palusn~e 75 forma simplex, and the herb~ F~/jSf~n/tn TP1Pmateia, is sf lect~cl from the group con~i~ting of Equisetum Telemateia var. pauciramosum, and Fquic~t~/1n Telemate~aforma mul~i,u"",.osum The second herb of the family Julianiaceae, genus amp~ipterygium adstringen~s is selected from the group con~i~tinsg of c~l~rh~ t~
CA 0224193~ 1998-06-29 W O 97/25997 PCTrUS97100428 The method of manufacturing an anti-hemorrhoidal composition includes the steps of ~1mixing an effective amount of a first herb of the genus F1~;sernc~e and an effective amount of a second herb of the family Julianiaceae, genus amphiprerygium adstrin~ens with a solvent to obtain a herbal mixture. The herbal mixture is heated for an effective time period to obtain a prepared herbal mixture. Preferably, the solvent is water. Optionally, the method includes the step of steeping the prepared herbal mixture to obtain a steeped herbal mixture and sifting the steeped herbal mixture to obtain a substantially purified herbal tea. Optionally, the antihemorrhoidal composition is packaged. p~k:~ing includes a tea bag, a capsule. a tablet. a concentrated liquid. and a powdered mixture. Preferably, the first herb and the second herb are separately pulverized in a blender and then mixed in a volume ratio of 1 to 1. Similarly, such a pulverizahon will generally result in a weight ratio of first herb to second herb of one to two. ~3y way of example, the first herb is half as heavy as the second herb.
The method of treating hemorrhoids provided herein includes the step of periodically ingesting a thelal.e~lically effective amount of the composition descrihed above. It is a further object of the present invention to solve the problems articulaled in the background section of the invention. The obiects and features of the present invention, other than those specifically set forth above. wi~l become apparent in the detailed description of the invention set forth below.
Bl~FF I)ESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of the kit of the presen~ invention.
SUBSTiTUTE SHEET (RULE 26) W O 97/25997 PCT~US97/00428 D'E~AILED DESCRI~ON OF THE INVENTION
The invention is based upon the discovery that ingestion of a processed composition of maner of a first her~ of the genus Fq~ etncpne and a second herb of the Generie Ju~ian a, family Julzanzaceae, genus ~",~,J~t~"~gzum ads~ingens (also known as l'C'~ h-AlAl-At~") as active ingredients relieves helllorllloidal ~ylll~tullls and reduces the swelling of hemorrhoids. Periodic ;ng~stion of a l11elAI~ ..r;~--Ally effective amount of this ~~ollllJo:,ition relieves hemorrhoidal symptoms within a short period of time.
T~e herb of the genus F~ ptncpne is selected from the group concict;ng of 10 Horsetail (also known as "~.~n~ llo"), F1rri~e~rl-7z nrvense (also known as "Corn Horsetail" and "Field Horsetail"), Fyr~isptr~m hyemale (also known as "Common Scouring Rush"), Fqr~i~et~r~m fiuvzat.ile, Fq~ en~m ~";"~ "., F~ Ptr~rn li~orale, Fqr~isetrlrn palustre~ Fqr~i~et~ "ul~"se~ Fqr~i~Ptr~m scirpoides (~so known as "Dwarf Scouring Rush"), F~ ptr~m sylvaticum {also known as ~Wood Horsetail~'), Fqr~ice~~m 7tPmAtpin~ Fqrli~pn~m variegatum (also known as "~ariegated Rush"), FAltri~et debile, F~irr~ Pn~rn elQngA~ n, Fqui~P~m gi~ c~ and Fqr/i~m~n m~ ~1".~
Fqr/i~et;.~m arvense (also known as "Great River ~Iorsetail" in one variant) is selected from the group con~;cl;--s~ of Fqr~ Ptr~qt arvense var. boreale, Fq~r/i~eh~m arvense forma alpestre, Fqu jsPtr/m arvense forma c, ".yc~/re, Fquiset~m arvense forma 20 diffusum, Fqr~i~etr~rr. arvense forrnapseudo-alpestre, Fq~ic~r.~m arvense formapseudo-silva~icum, Fq~ etr~m arvense forma pseudo-vari~m, F~i~err~m arvense forma r~ rr~ sr~m, and F~lr~iseh~ ,"e forma varium.
Fqujsetr~tn hyemale is selected from the group CQncictin~ of Fquic~trr~l hyemalevar. affine (also known as "Fyuic.~ l Prealtum"). Fq~/icetr/m hyemale var.
2~ in~ermedi~m, Fqr~isetr/rn hyemale var. r-ubustum, F~7r~i~err~m hyemale forma polystachyum, ~quiset~n hyemcrle forrna proliferum, and Fq"iser"rn hyemale formapumilum.
-F~ icPrr~r. palustre is selected from the group Concicting of Fql~isPr~n palustre forma arcuarum, F~r~ Pt~ r. palustre forma filiforme, F~ ;sPr~m palustre forma fluirans, F~ Pt~r. palustre forma nigridens, F~ Pr~n palustre forma polystachion, Fq~isett/m palustre forma rn,~ Qs~n, Fq~ >n palustre forrna vertir;('~ m, and 5 F;7~ et~rr. palustre forma srmplex.
F~l~iceh~tn TelomntPi~r is s lected from the group cu,.~;c~ p of F~ iset~ r.
T~7P~nnto; r var. pszuciramosum, and Fqr~iset~n ~elemateia forma multirammosum.
~ isett~r. Variegatum is selected from the group Concicting of Equise~um Vanegatum var. JesupL' and Fq~ pt~7~m V~riegatum var. nelsoni.
The form in which the COul~ ,iliOù is 5l-rp~ A to the consumer is not critical.
It is possible that the CC~ yOSiliOll can be supplied as a homogeneously blendedpowder of the desired l~.o~ollion of the requisite herbs. It is further possible that the homogeneously blended powder could be combined with binding agents and formed into water soluble pills and tab}ets. These pills and tablets can be co~nyl~s~d and 15 ~h~p~d In acco~dallce with the method of the invendon, a the.a~u~ically effective amount of the col.lpo:-ition is ingesteA when sylllylulns of hemorrhoidal :,uf~-ing are e-~yel;enced. Typically, a ther~c~Lically effective ~ ILily is one cup of tea ingested three times a day for a period of one week. One cup daily is then further ingect~A for 20 a~lu~ ately another week. Larger ql-~nhtieS of tea are ingl~ct.oc~ for longer periods of time in cases where the hemorrhoids are severe. The dosage may be ad3usted bythe user to ~rço.~ A~t~ ~lirrGlGl~ces in body weight and se~ y of the sy.."ulul.-s.
~re~mn.ont is continued until re}ief of hemorrhoidal syln~ s and reduction of hemorrhoidal swelling has been achieved.
'~5 The present invention further conteTnplates the addition of unobjectionable adjuv~.llts to the herbal cc,lllpo~i~ion such a~s natural and artificial sweer~nPr-S, inert teas, natural flavors, artificial flavors, and coloring agents. Sldlled practitioners recognize that addition of the adjuvants affect the weight and volume of the dosage CA 0224l935 l998-06-29 W O 97/25997 PCTrUS97/00428 of the herbs at issue. Hence, adjustment of the dosage to account for the ~rcse.-ce of the ad~uvant is within the skill of the suppiiers of the ac}juvd,lt products.
FIG. 1 illustr~7tes a pe~ ,ccliv~ view of a kit of the present invention. The kit comprises a container 100 in which a plurality of tea bags 200. Tea bags 20{) consist S - of a permeable mc~.blane or filter commonly made of paper as is known in the art.
Preferably, there are in the range of three to over twenty tea bags 200 in co~lL~inEr 100 so that a user has a sufficient quantitv of tea bags 200 having the compositiOns c1~oscribed herein for a full, complete treatment of the condition. Preferably, a standardized dosage includes twenty eight (28) tea bags. It is understood that any 10 number of tea bags 200 are used in the kit sufflcient to provide a the~a~uLic effect for a subJect. A basic yr~ ion kit includes sllffiçient tea bags to make 3 cups ~3 bags) per day for 7 days (71 units) and sllfficient tea bags to m3ke-1 cup (1 bag) per day for 7 days (7 units) for a mil ilL...~ll total of about 28 units. It is ~.lde.l~,lood that the number of tea bags can be in the range of 1 bag to over 200 bags deper~ ng on 15 the needs of the sub3ect.
FY~mrles of m~kin~ the various cOI~lpO~ ;Q~:ls d~ ibed herein are provided in the e~amples provided below. ~aw crushed ingle~l;enls and/or pulverized ingredients were used herein. Where leaspoons of ingredients were used, the ingredients were generally e~tremely fine particles that were pulverized Where 20 tablespoons of ingredients were used, the ingredients were generally crushed and include coarse particles.
IP~.F. 1 An anti-hemorrhoidal tea was made from the ~l-i.1~L~-C; of two herbs: a first herb of the genus F~tlis.orac~ne and a second herb of the Generie Juliania, farnily :2~; Julianiaceae, genus amphip~erygium adsmngerts. In particular, about one level tablespoon of crushed cu~-~h~ t.o herb and one heaping tablespoon of Horsetail herb were added to three cups of cold water in a tea kettle to create a mixture. The Illix~ e was brought to a boil for one minute and allowed to steep for five minut~C
-W O 97l25997 PCTAUS97/00428 to form a tea. The tea was then poured into a cup through a sifter, and ingested by a user while still warrn. One cup of tea was ingested three times a da- for a period of one week. One cup daily was then further inPes~ed for a~ru~,atelv another week. The ~f~icti~n of hemorrhoids wac then cured. Larger ~t-~nti~j~s of tea areS ingested for ionger periods of time in cases where the hemorrhoids are severe.The grounds of the above ~ u,c were also used for a second ~repaia~ion.
The reTn~ining grounds frorn the preparations tiiCCllC~ above were added to three cups of ~ater. The mi~ture was allowed to soak overnight. The ne~t morning the mi~cture was brought to a boi} and then inpester3 as ~iiCCl~CC~d above. A base dosage 10 of the tea was a dosage taken over a period of time of about 14 days in one variant, again depen~lin~ on the ~ LiLy of the condition.
Mp~.F. 2 Another e~cample of the anti-hemorrhoidal tea was made from the mi~ure of two herbs: a first herb of the genus F~ sPt~ ne and a second herb of the Generie1~ Juluznia, farnilyJ~ ninr~ne~genus amph~pterygiumadstrin~ens. Preferably,percup of solvent, e.g. hot water, about 1/2 level teaspoon of pulverized hol~L~il and CT-~h~ t~ Lul~ (or about lJ4 teaspoon horsetail and about 1/4 teaspoon ofc~l~rh~ t~) was used. In ~ tic~r~ to the ratios of first herb to second herb above, vanous weight and volurne ratios of the r. ;.~,cc~ive herbs were used herewith to obtain 20 an effective amount of the combination of the two herbs. ~:~empl~ry ratios of the firs~
herb to the second herb by weight include ratios of about one to about ten first her~
to about one to about ten second her~. F~m~l~ry ratios of the first herb by volume to the second herb include ratios of about one to about ten first herb to about one to about twenty second her~. I,arger quantities of tea were ings:sted for lon er periods ~S of time in cases where the hcmorrhoids were severe.
E;X~Mp~ F 3 A fifty year old male subject Ai~ ~rl with hemmorhoids that included pain and bleeding ~ .essfully utili7~r1 numerous hemmorhoid remt~lies includin sitz W O 97/2S997 PCT~US97/00428 baths, suppositories, and ligation. The male subject utilized the invention dcs~lii.ed above under the protocol described above for a period of three weeks. The hemmorhoids were succeccfully treated.
F~ ~pL~ 4 Male subject 5UCr~ lg from hemmorhoids for the iast twenty-five years.
During acute hemmorhoid flare up, subject injested two cups per day of the tea described above for a period of ten days. The hemmorhoids were s-t~c~ccfully treated.
F~MpLE ~
Forty year old male subject s.~ g from h~ olh:~ids for two weeks injested three cups per day of the tea rlr.srrihe~ a'~ove for a period of two days. Th~e hemmorhoids were .~cc~ rully treated, and the her~norhoidal symptoms disappeared.
El~MPLE 6 Forty-four year old male subject s,~ e"~.g from hemmorhoids for ilnately one month injested two cups per day of the tea des~libcd above for a period of three days in conjunction with topical applirztti-~n of Anusol~ cream. The hemmorhoidal :~yllll~tOlllS disa~a~d.
The present invention also int~hl~s a li~uified, ready-to-serve coll.posi~ion for the alleviation of hemo;rhoir~ 7y~ t~ c such ac a iced tea (one made from a 20 powdered con~ e,.L~s)) and the like. In this variant a variety of additions are added to the first herb of the genus F~r~is~ ne and the seco.~d herb of the Generie Juliania, family Julianiaceae, genus amphip~erygium adstringens.
By way of e~mpl~ acidulents are select~A from the group concicting of fumaric acid, citric acid, malic acid, and ascorbic acid. Of course, other suitable arif~ r~tc can also be used herein. Ascorbic acid is a desired con~ ucnt of the r~ ion both for its vitamin acti~rity and also since it acts as an o~vgen scavenger-in~t~s are also added thereto. Algin~t~s can include propylene glycol (0.1 W O 97/25997 PCT~US97/00428 to 0.'7~c) to s~Spen~l fruit pulp in a fluid of the herbs for added taste. Further carrageenan is alco used in the present invention to improve the mouth feel of the herbal preparation. Furcellaran is also used at about (0.0~%) to stabilize fruit pulp in the beverage where needed. Gum arabic is also used to optionally stabilize the S preparation.
Optionally, the composition comprises a constituent select~orl from the group concicting of vil~ul~ S and minerals. F~cempl~ry vitamins contained therein include vitamin A, vitamin B col.lple~ (and the CO~I~,Liluerits thereof), vitarnin C, vitarnin D~
riboflavin? lactoflavin, flavin, nicotine acid, Betu~in c~ ,o.~ld, ascorbic acid, thiamin, 10 thi~mine hydrochloride, thi~min~ chloride, bet~t~in, betu}in, ni~rin~mi~le, niacin, calcium, pantothenate, pantothenic acid, nicotin~m~ pyrirlo~rine, and l~leu~helol.
Exemplary minerals include r~lçiLIm~ ~hos~hoLus, and m~gnr~;...", iron, iodine, zinc, and copper. Fiber inrl~ in~ cel}ulose and other non-~ligtoct~hle cell-wall polymers of plant origin can also be added as nPeA~
1~ The ready to serve variant of the composition further inrill~ec an optional color addi~ . Color additives are natural color ad,iiliv~s or artificial color additives.
Color additives are selected from the group co..c;~ of Yellow No. 5, Yellow No.
6, Red Nos.'~-4, Blue Nos. 1-~, Violet No.1, Green No. 3, and Orange B. The color additives described herein are simply examples of the various color additives used in 20 the present invention. By way of e~ample, the FD & C dyes are also used herein.
Exemplary uses of color additives herein include adding effective amourlts of color addi~i~,cs to the herbal ~ r~l;on to obtain the following concentrations of color additive in the p.e~aLalion in parts per million ~ppm):
-- flavor-orange: FD&C yellow #6 -- in the range of 50-75 ppm; and, FD&C
'~5 Red #40 of about 5-10 ppm.
~ flavor-cherrv: FD&C red #40 -- in the range of 50-?S ppm: and, FD&C Blue #1 of about 100 ppm.
~ flavor-sL~dwl,crrv: FD&C red #40 -- in the range of 50-60 ppm.
t 11 ' ~ flavor-lemon: FD&C yellow ~5 -- in the range of 10-'70 ppm.
~ ffavor-cola or root beer: caramel color in the range of 200-600 ppm.
The resultant color additive should impart mi~r;,..ll"l color to the herbal preparation, and dissolve without showing the individual co,ilponent colors. To obtain ma~imum color, dissolved color is added in solution followed by a moisture removing operation. The showing of individual coll,~ ent colors is minimi7P~1 with the use or wet-dry blends.
The herbal pre~ardLion optionally compi-ises a natural ~avor. Natural flavors include es~P~ ti~l oils, protein hydrolysate, rli~ti~l~t~" or any products of roasting, 10 heating, or enzymo~ysis which retains flavoring constituents derived from a spice, vegetable, edible yeast, herb, bark, bud, root, leaf, fruit or fruit juice concentration.
or similar plant material.
The her~al preparation is optiona,ly s~lhst~ntiz~lly tableted, c~rs~ t~ uified.
and or powdered. Tableting includes e~erting a high ~I. ssule on the herbal 15 ~l~p&~aLion to obtain a suitable size and particle distribution. The herbai preparation is first gr~m7l~tpd Gr~n~ tion is ac~o...l-liche-l by a number of suitable methods bv slugging and adding a gr~ ting liquid while mi~ing the herbal prep~r~on. With slugging, the herbal preparation is run through a tablet press producing a cv~ -esscd tablet. This tablet is then ground and screened to produce a gr~n~ hon. An aqueous binder is ~en added thereto in a mi~cer. After agglomeration, the r~sllltin~ material is then dried, ground and a~! lv~liately se.ecl~ed.
Optio~lly, EDTA is added as a p~s~lvalive. Where constituents are referred to as co~ ising the herbal ~el~aralion it is ~os~iblc that the powdered mi~cmre COIl~iaL~ ecce~Si~lly of, or only co~si~Ls of these constituents.
While both volume and weight ratios may be used in the practice of the invention, and both provide adequa~e results, volumes ratios are prefered.
While only a few, preferrêd embo-1imentc of the invention have been described hereinabove. those of ordinary skill in the art will recogni~ that the embodiment may W O 97/25997 PCTrUS97/00428 be motlifie~ and altered without departing from the cent~al spirit a~d scope of the inven~ion. Thus, the preferred embo~imPnt describ~ed he~eina}x ve is to be considered in a~l respects as i~ Te and not ~ ivc, the scope of the inven~ion being inti~ t~-cl by the ~rpen~l~d cla~ms, rather thaD. by the f~,r.,~c,i"g ~r~ , and all 5 cha~ s which come within the m~ning and range of ec~uivalency of tne ciaims are irlt~nAeA to be em'oraced herein.
-F~ icPrr~r. palustre is selected from the group Concicting of Fql~isPr~n palustre forma arcuarum, F~r~ Pt~ r. palustre forma filiforme, F~ ;sPr~m palustre forma fluirans, F~ Pt~r. palustre forma nigridens, F~ Pr~n palustre forma polystachion, Fq~isett/m palustre forma rn,~ Qs~n, Fq~ >n palustre forrna vertir;('~ m, and 5 F;7~ et~rr. palustre forma srmplex.
F~l~iceh~tn TelomntPi~r is s lected from the group cu,.~;c~ p of F~ iset~ r.
T~7P~nnto; r var. pszuciramosum, and Fqr~iset~n ~elemateia forma multirammosum.
~ isett~r. Variegatum is selected from the group Concicting of Equise~um Vanegatum var. JesupL' and Fq~ pt~7~m V~riegatum var. nelsoni.
The form in which the COul~ ,iliOù is 5l-rp~ A to the consumer is not critical.
It is possible that the CC~ yOSiliOll can be supplied as a homogeneously blendedpowder of the desired l~.o~ollion of the requisite herbs. It is further possible that the homogeneously blended powder could be combined with binding agents and formed into water soluble pills and tab}ets. These pills and tablets can be co~nyl~s~d and 15 ~h~p~d In acco~dallce with the method of the invendon, a the.a~u~ically effective amount of the col.lpo:-ition is ingesteA when sylllylulns of hemorrhoidal :,uf~-ing are e-~yel;enced. Typically, a ther~c~Lically effective ~ ILily is one cup of tea ingested three times a day for a period of one week. One cup daily is then further ingect~A for 20 a~lu~ ately another week. Larger ql-~nhtieS of tea are ingl~ct.oc~ for longer periods of time in cases where the hemorrhoids are severe. The dosage may be ad3usted bythe user to ~rço.~ A~t~ ~lirrGlGl~ces in body weight and se~ y of the sy.."ulul.-s.
~re~mn.ont is continued until re}ief of hemorrhoidal syln~ s and reduction of hemorrhoidal swelling has been achieved.
'~5 The present invention further conteTnplates the addition of unobjectionable adjuv~.llts to the herbal cc,lllpo~i~ion such a~s natural and artificial sweer~nPr-S, inert teas, natural flavors, artificial flavors, and coloring agents. Sldlled practitioners recognize that addition of the adjuvants affect the weight and volume of the dosage CA 0224l935 l998-06-29 W O 97/25997 PCTrUS97/00428 of the herbs at issue. Hence, adjustment of the dosage to account for the ~rcse.-ce of the ad~uvant is within the skill of the suppiiers of the ac}juvd,lt products.
FIG. 1 illustr~7tes a pe~ ,ccliv~ view of a kit of the present invention. The kit comprises a container 100 in which a plurality of tea bags 200. Tea bags 20{) consist S - of a permeable mc~.blane or filter commonly made of paper as is known in the art.
Preferably, there are in the range of three to over twenty tea bags 200 in co~lL~inEr 100 so that a user has a sufficient quantitv of tea bags 200 having the compositiOns c1~oscribed herein for a full, complete treatment of the condition. Preferably, a standardized dosage includes twenty eight (28) tea bags. It is understood that any 10 number of tea bags 200 are used in the kit sufflcient to provide a the~a~uLic effect for a subJect. A basic yr~ ion kit includes sllffiçient tea bags to make 3 cups ~3 bags) per day for 7 days (71 units) and sllfficient tea bags to m3ke-1 cup (1 bag) per day for 7 days (7 units) for a mil ilL...~ll total of about 28 units. It is ~.lde.l~,lood that the number of tea bags can be in the range of 1 bag to over 200 bags deper~ ng on 15 the needs of the sub3ect.
FY~mrles of m~kin~ the various cOI~lpO~ ;Q~:ls d~ ibed herein are provided in the e~amples provided below. ~aw crushed ingle~l;enls and/or pulverized ingredients were used herein. Where leaspoons of ingredients were used, the ingredients were generally e~tremely fine particles that were pulverized Where 20 tablespoons of ingredients were used, the ingredients were generally crushed and include coarse particles.
IP~.F. 1 An anti-hemorrhoidal tea was made from the ~l-i.1~L~-C; of two herbs: a first herb of the genus F~tlis.orac~ne and a second herb of the Generie Juliania, farnily :2~; Julianiaceae, genus amphip~erygium adsmngerts. In particular, about one level tablespoon of crushed cu~-~h~ t.o herb and one heaping tablespoon of Horsetail herb were added to three cups of cold water in a tea kettle to create a mixture. The Illix~ e was brought to a boil for one minute and allowed to steep for five minut~C
-W O 97l25997 PCTAUS97/00428 to form a tea. The tea was then poured into a cup through a sifter, and ingested by a user while still warrn. One cup of tea was ingested three times a da- for a period of one week. One cup daily was then further inPes~ed for a~ru~,atelv another week. The ~f~icti~n of hemorrhoids wac then cured. Larger ~t-~nti~j~s of tea areS ingested for ionger periods of time in cases where the hemorrhoids are severe.The grounds of the above ~ u,c were also used for a second ~repaia~ion.
The reTn~ining grounds frorn the preparations tiiCCllC~ above were added to three cups of ~ater. The mi~ture was allowed to soak overnight. The ne~t morning the mi~cture was brought to a boi} and then inpester3 as ~iiCCl~CC~d above. A base dosage 10 of the tea was a dosage taken over a period of time of about 14 days in one variant, again depen~lin~ on the ~ LiLy of the condition.
Mp~.F. 2 Another e~cample of the anti-hemorrhoidal tea was made from the mi~ure of two herbs: a first herb of the genus F~ sPt~ ne and a second herb of the Generie1~ Juluznia, farnilyJ~ ninr~ne~genus amph~pterygiumadstrin~ens. Preferably,percup of solvent, e.g. hot water, about 1/2 level teaspoon of pulverized hol~L~il and CT-~h~ t~ Lul~ (or about lJ4 teaspoon horsetail and about 1/4 teaspoon ofc~l~rh~ t~) was used. In ~ tic~r~ to the ratios of first herb to second herb above, vanous weight and volurne ratios of the r. ;.~,cc~ive herbs were used herewith to obtain 20 an effective amount of the combination of the two herbs. ~:~empl~ry ratios of the firs~
herb to the second herb by weight include ratios of about one to about ten first her~
to about one to about ten second her~. F~m~l~ry ratios of the first herb by volume to the second herb include ratios of about one to about ten first herb to about one to about twenty second her~. I,arger quantities of tea were ings:sted for lon er periods ~S of time in cases where the hcmorrhoids were severe.
E;X~Mp~ F 3 A fifty year old male subject Ai~ ~rl with hemmorhoids that included pain and bleeding ~ .essfully utili7~r1 numerous hemmorhoid remt~lies includin sitz W O 97/2S997 PCT~US97/00428 baths, suppositories, and ligation. The male subject utilized the invention dcs~lii.ed above under the protocol described above for a period of three weeks. The hemmorhoids were succeccfully treated.
F~ ~pL~ 4 Male subject 5UCr~ lg from hemmorhoids for the iast twenty-five years.
During acute hemmorhoid flare up, subject injested two cups per day of the tea described above for a period of ten days. The hemmorhoids were s-t~c~ccfully treated.
F~MpLE ~
Forty year old male subject s.~ g from h~ olh:~ids for two weeks injested three cups per day of the tea rlr.srrihe~ a'~ove for a period of two days. Th~e hemmorhoids were .~cc~ rully treated, and the her~norhoidal symptoms disappeared.
El~MPLE 6 Forty-four year old male subject s,~ e"~.g from hemmorhoids for ilnately one month injested two cups per day of the tea des~libcd above for a period of three days in conjunction with topical applirztti-~n of Anusol~ cream. The hemmorhoidal :~yllll~tOlllS disa~a~d.
The present invention also int~hl~s a li~uified, ready-to-serve coll.posi~ion for the alleviation of hemo;rhoir~ 7y~ t~ c such ac a iced tea (one made from a 20 powdered con~ e,.L~s)) and the like. In this variant a variety of additions are added to the first herb of the genus F~r~is~ ne and the seco.~d herb of the Generie Juliania, family Julianiaceae, genus amphip~erygium adstringens.
By way of e~mpl~ acidulents are select~A from the group concicting of fumaric acid, citric acid, malic acid, and ascorbic acid. Of course, other suitable arif~ r~tc can also be used herein. Ascorbic acid is a desired con~ ucnt of the r~ ion both for its vitamin acti~rity and also since it acts as an o~vgen scavenger-in~t~s are also added thereto. Algin~t~s can include propylene glycol (0.1 W O 97/25997 PCT~US97/00428 to 0.'7~c) to s~Spen~l fruit pulp in a fluid of the herbs for added taste. Further carrageenan is alco used in the present invention to improve the mouth feel of the herbal preparation. Furcellaran is also used at about (0.0~%) to stabilize fruit pulp in the beverage where needed. Gum arabic is also used to optionally stabilize the S preparation.
Optionally, the composition comprises a constituent select~orl from the group concicting of vil~ul~ S and minerals. F~cempl~ry vitamins contained therein include vitamin A, vitamin B col.lple~ (and the CO~I~,Liluerits thereof), vitarnin C, vitarnin D~
riboflavin? lactoflavin, flavin, nicotine acid, Betu~in c~ ,o.~ld, ascorbic acid, thiamin, 10 thi~mine hydrochloride, thi~min~ chloride, bet~t~in, betu}in, ni~rin~mi~le, niacin, calcium, pantothenate, pantothenic acid, nicotin~m~ pyrirlo~rine, and l~leu~helol.
Exemplary minerals include r~lçiLIm~ ~hos~hoLus, and m~gnr~;...", iron, iodine, zinc, and copper. Fiber inrl~ in~ cel}ulose and other non-~ligtoct~hle cell-wall polymers of plant origin can also be added as nPeA~
1~ The ready to serve variant of the composition further inrill~ec an optional color addi~ . Color additives are natural color ad,iiliv~s or artificial color additives.
Color additives are selected from the group co..c;~ of Yellow No. 5, Yellow No.
6, Red Nos.'~-4, Blue Nos. 1-~, Violet No.1, Green No. 3, and Orange B. The color additives described herein are simply examples of the various color additives used in 20 the present invention. By way of e~ample, the FD & C dyes are also used herein.
Exemplary uses of color additives herein include adding effective amourlts of color addi~i~,cs to the herbal ~ r~l;on to obtain the following concentrations of color additive in the p.e~aLalion in parts per million ~ppm):
-- flavor-orange: FD&C yellow #6 -- in the range of 50-75 ppm; and, FD&C
'~5 Red #40 of about 5-10 ppm.
~ flavor-cherrv: FD&C red #40 -- in the range of 50-?S ppm: and, FD&C Blue #1 of about 100 ppm.
~ flavor-sL~dwl,crrv: FD&C red #40 -- in the range of 50-60 ppm.
t 11 ' ~ flavor-lemon: FD&C yellow ~5 -- in the range of 10-'70 ppm.
~ ffavor-cola or root beer: caramel color in the range of 200-600 ppm.
The resultant color additive should impart mi~r;,..ll"l color to the herbal preparation, and dissolve without showing the individual co,ilponent colors. To obtain ma~imum color, dissolved color is added in solution followed by a moisture removing operation. The showing of individual coll,~ ent colors is minimi7P~1 with the use or wet-dry blends.
The herbal pre~ardLion optionally compi-ises a natural ~avor. Natural flavors include es~P~ ti~l oils, protein hydrolysate, rli~ti~l~t~" or any products of roasting, 10 heating, or enzymo~ysis which retains flavoring constituents derived from a spice, vegetable, edible yeast, herb, bark, bud, root, leaf, fruit or fruit juice concentration.
or similar plant material.
The her~al preparation is optiona,ly s~lhst~ntiz~lly tableted, c~rs~ t~ uified.
and or powdered. Tableting includes e~erting a high ~I. ssule on the herbal 15 ~l~p&~aLion to obtain a suitable size and particle distribution. The herbai preparation is first gr~m7l~tpd Gr~n~ tion is ac~o...l-liche-l by a number of suitable methods bv slugging and adding a gr~ ting liquid while mi~ing the herbal prep~r~on. With slugging, the herbal preparation is run through a tablet press producing a cv~ -esscd tablet. This tablet is then ground and screened to produce a gr~n~ hon. An aqueous binder is ~en added thereto in a mi~cer. After agglomeration, the r~sllltin~ material is then dried, ground and a~! lv~liately se.ecl~ed.
Optio~lly, EDTA is added as a p~s~lvalive. Where constituents are referred to as co~ ising the herbal ~el~aralion it is ~os~iblc that the powdered mi~cmre COIl~iaL~ ecce~Si~lly of, or only co~si~Ls of these constituents.
While both volume and weight ratios may be used in the practice of the invention, and both provide adequa~e results, volumes ratios are prefered.
While only a few, preferrêd embo-1imentc of the invention have been described hereinabove. those of ordinary skill in the art will recogni~ that the embodiment may W O 97/25997 PCTrUS97/00428 be motlifie~ and altered without departing from the cent~al spirit a~d scope of the inven~ion. Thus, the preferred embo~imPnt describ~ed he~eina}x ve is to be considered in a~l respects as i~ Te and not ~ ivc, the scope of the inven~ion being inti~ t~-cl by the ~rpen~l~d cla~ms, rather thaD. by the f~,r.,~c,i"g ~r~ , and all 5 cha~ s which come within the m~ning and range of ec~uivalency of tne ciaims are irlt~nAeA to be em'oraced herein.
Claims (22)
1. A composition consisting essentially of a first herb of the genus Equisetaceae and a second herb of the genus amphipterygium adstringens.
2. The composition of claim 1 in solid form.
3. The composition of claim 2 plus a solvent.
4. The composition of claim 3 in which the solvent is water.
5. The composition of claim 1 in which said herb of the genus Equisetaceae is selected from the group consisting of Horsetail, Equisetum arvense, Equisetum hyemale, Equisetum fluviatile, Equisetum kansanum, Equisetum litorale, Equisetum palustre, Equisetum pratense, Equisetum scirpoides, Equisetum sylvaticum, Equisetum Telemateia, Equisetum variegatum, Equisetum debile, Equisetum elongatum, Equisetum giganteum and Equisetum maximum.
6. The composition of claim 5 in which said Equisetum arvense is selected from the group consisting of Equisetum arvense var. boreale, Equisetum arvense forma alpestre, Equisetum arvense forma campestre, Equisetum arvense forma diffusum, Equisetum arvense forma pseudo-alpestre, Equisetum arvense forma pseudo-sylvaticum, Equisetum arvense forma pseudo-varium, Equisetum arvense forma ramulosum, and Equisetum arvense forma varium.
7. The composition of claim 5 in which said Equisetum hyemale is selected from the group consisting of Equisetum hyemale var. affine, Equisetum hyemale var.
intermedium, Equisetum hyemale var. rubustum, Equisetum hyemale forma polystachyum, Equisetum hyemale forma proliferum, and Equisetum hyemale forma pumilum.
intermedium, Equisetum hyemale var. rubustum, Equisetum hyemale forma polystachyum, Equisetum hyemale forma proliferum, and Equisetum hyemale forma pumilum.
8. The composition of claim 5 in which said Equisetum palustre is selected from the group consisting of Equisetum palustre forma arcuatum, Equisetum palustre forma filiforme, Equisetum palustre forma fluitans, Equisetum palustre forma nigridens, Equisetum palustre forma polystachion, Equisetum palustre forma ramulosum, Equisetum palustre forma simplex and Equisetum palustre forma verticilatum.
9. The composition of claim 5 in which said Equisetum Telemateia is selected from the group consisting of Equisetum Telemateia var. pauciramosum and Equisetum Telemateia forma multirammosum.
10. The composition of claim 5 in which said Equisetum variegatum is selected from the group consisting of Equisetum variegatum var. jesupi and Equisetum variegatum var. nelsoni.
11. The composition of claim 1 in which said second herb is cuachalalate.
12. The composition of claim 5 in which said second herb is cuachalalate.
13. The composition of claim 6 in which said second herb is cuachalalate.
14. The composition of claim 7 in which said second herb is cuachalalate.
15. The composition of claim 8 in which said second herb is cuachalalate.
16. The composition of claim 9 in which said second herb is cuachalalate.
17. The composition of claim 10 in which said second herb is cuachalalate.
18. The composition of claim 1 in which the volume of the first herb of the genus Equisetaceae has a volume ratio of about 1:1 with the volume of the second herb of the genus amphipterygium adstringens.
19. The composition of claim 1 in which the weight of the first herb of the genus Equisetaceae has a weight ratio of about 1:2 with the weight of the second herb of the genus amphipterygium adstringens.
20. The composition of claim 2 in which said solid form is selected from the group consisting of powder, capsules and tablets.
21. The composition of claim 20 in which said solid form is powder in a liquid permeable container.
22. The composition of claim 21 in which said liquid is water.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/585833 | 1996-01-16 | ||
| US08/585,833 US5869059A (en) | 1996-01-16 | 1996-01-16 | Herbal composition for hemorrhoid treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2241935A1 true CA2241935A1 (en) | 1997-07-24 |
Family
ID=24343147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002241935A Abandoned CA2241935A1 (en) | 1996-01-16 | 1997-01-15 | Tea, kit and method for treating hemorrhoids |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5869059A (en) |
| EP (1) | EP0874636A4 (en) |
| JP (1) | JP2001515463A (en) |
| CN (1) | CN1208352A (en) |
| AU (1) | AU1746297A (en) |
| CA (1) | CA2241935A1 (en) |
| WO (1) | WO1997025997A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228387B1 (en) * | 2000-01-27 | 2001-05-08 | Murray Borod | Integrated comprehensive hemorrhoid treatment compositions and regimen |
| US8642051B2 (en) * | 2000-03-21 | 2014-02-04 | Suzanne Jaffe Stillman | Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s) |
| US6365198B1 (en) * | 2001-01-28 | 2002-04-02 | Gulf Pharmaceutical Industries | Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids |
| US7090858B2 (en) * | 2001-08-09 | 2006-08-15 | Swaminathan Jayaraman | Coated filter bag material for oral administration of medicament in liquid and methods of making same |
| US20060008536A1 (en) * | 2004-07-08 | 2006-01-12 | Jdc Pharmaceutical | Pharmaceutical compositions and methods of use |
| US7250445B1 (en) * | 2005-01-14 | 2007-07-31 | Ehrenpreis Eli D | Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders |
| US9392814B2 (en) | 2014-06-06 | 2016-07-19 | Nicholas J. Singer | Delivery system for drinks |
| USD773313S1 (en) | 2015-06-23 | 2016-12-06 | Nicholas J. Singer | Package |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US272138A (en) * | 1883-02-13 | Maey g | ||
| US481815A (en) * | 1892-08-30 | Medical compound | ||
| US1383896A (en) * | 1920-09-01 | 1921-07-05 | R H Chitwood | Ointment |
| US1890596A (en) * | 1930-05-07 | 1932-12-13 | Zographos George | Remedy for hemorrholds |
| US3062716A (en) * | 1960-02-08 | 1962-11-06 | Applic Chimiques D Etudes Et D | Method of treating hemorrhoids |
| GB1056388A (en) * | 1964-04-23 | 1967-01-25 | Yves Rocher | Therapeutically useful ranunculus extracts |
| US3534102A (en) * | 1967-09-06 | 1970-10-13 | David A Waldstein | Reaction products of elemental iodine and alkoxylated alkylamine oxides |
| CA920950A (en) * | 1968-07-19 | 1973-02-13 | Hunger Alfred | Anti-haemorrhoidally active preparations for rectal administration |
| US3781424A (en) * | 1970-07-21 | 1973-12-25 | E Ponvert | Hemorrhoid treatment preparation produced from hot cherry peppers |
| US4118480A (en) * | 1973-02-09 | 1978-10-03 | Charles V. Stoelker | Pharmaceutical preparation for treating hemorrhoids and anal fissures |
| US3935310A (en) * | 1974-03-07 | 1976-01-27 | Homan John D | Remedy for treatment of hemorrhoids |
| ES456574A1 (en) * | 1977-03-07 | 1978-02-16 | Rocador Sa | Quercetin pentamethyl carbamate and a process for its preparation |
| US4169143A (en) * | 1978-07-10 | 1979-09-25 | Irving Haimowitz | Method for treating hemorrhoid symptoms and composition for use therein |
| US4192866A (en) * | 1978-10-10 | 1980-03-11 | Ralph Anderson | Anorectal medication |
| US4265887A (en) * | 1979-12-11 | 1981-05-05 | Breskman Joseph S | Composition and method for treatment of hemorrhoids |
| US4383986A (en) * | 1981-08-17 | 1983-05-17 | Ortho Pharmaceutical Corporation | Hemorrhoidal compositions |
| FR2581310B1 (en) * | 1985-05-02 | 1988-09-23 | Natura Medica Laboratoires | THERAPEUTIC COMPOSITION COMPRISING A-LINOLENIC ACID AND A COMPOUND CAPABLE OF PROMOTING ACID THROUGH THE CELL MEMBRANE AND PLANT EXTRACT COMPRISING THE ACID AND THE COMPOUND |
| US4626433A (en) * | 1985-05-20 | 1986-12-02 | Preparation Gold, Inc. | Remedy for hemorrhoids |
| US4761285A (en) * | 1986-10-28 | 1988-08-02 | Athanasios Vasiliou | Composition for relief and treatment of hemorrhoids |
| US5196405A (en) * | 1987-07-08 | 1993-03-23 | Norman H. Oskman | Compositions and methods of treating hemorrhoids and wounds |
| US4945084A (en) * | 1987-07-08 | 1990-07-31 | Norman Oksman | Method and composition for topically treating anorectal or other dermal wounds |
| IT8947616A0 (en) * | 1989-02-06 | 1989-02-06 | Verde Giancarlo Umberto | PREPARATION FOR THE TREATMENT AND CURE OF HEMORRHOIDS |
| US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
| US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
| EP0583482B1 (en) * | 1992-02-07 | 1999-12-29 | Kaken Pharmaceutical Co., Ltd. | Remedy for wound or hemorrhoid |
-
1996
- 1996-01-16 US US08/585,833 patent/US5869059A/en not_active Expired - Fee Related
-
1997
- 1997-01-15 CN CN97191714A patent/CN1208352A/en active Pending
- 1997-01-15 AU AU17462/97A patent/AU1746297A/en not_active Abandoned
- 1997-01-15 WO PCT/US1997/000428 patent/WO1997025997A1/en not_active Application Discontinuation
- 1997-01-15 EP EP97904749A patent/EP0874636A4/en not_active Withdrawn
- 1997-01-15 JP JP52608497A patent/JP2001515463A/en active Pending
- 1997-01-15 CA CA002241935A patent/CA2241935A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0874636A1 (en) | 1998-11-04 |
| EP0874636A4 (en) | 2000-03-29 |
| CN1208352A (en) | 1999-02-17 |
| WO1997025997A1 (en) | 1997-07-24 |
| AU1746297A (en) | 1997-08-11 |
| US5869059A (en) | 1999-02-09 |
| JP2001515463A (en) | 2001-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5498631A (en) | Method for treatment of menopausal and premenstrual symptoms | |
| KR101685506B1 (en) | Usage of composition comprising complex extracts of pomegranate and red clover as active ingredients | |
| US6261607B1 (en) | Composition for promoting prostate health containing selenium and herbal extracts | |
| Woodville | Medical Botany: Containing Systematic and General Descriptions, with Plates of All the Medicinal Plants, Indigenous and Exotic, Comprehended in the Catalogues of the Materia Medica, as Published by the Royal Colleges of Physicians of London and Edinburgh: Together with the Most of the Principal Medicinal Plants Not Included in Those Pharmacopoeias. Accompanied with a Circumstantial Detail of Their Medicinal Effects, and of the Diseases in which They Have Been Most Successfully Employed | |
| CA2241935A1 (en) | Tea, kit and method for treating hemorrhoids | |
| CN102764408A (en) | Dealcoholic preparation | |
| ITTO20010283A1 (en) | COMPOSITION OF HERBS AND MANUFACTURING PROCEDURE OF SUCH COMPOSITION FOR THE TREATMENT OF GYNECOLOGICAL DISORDERS. | |
| KR19980073990A (en) | Green tea drink containing herbal ingredients and its manufacturing method | |
| CN103230486B (en) | Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver | |
| KR100442771B1 (en) | Drink for mitigating hangover and the manufacturing method thereof | |
| CN103845633B (en) | It is a kind of to treat Chinese medicine composition of canker sore and preparation method thereof | |
| JP2003225072A (en) | Health supplement having improving action of urinary disturbance | |
| WO2015149393A1 (en) | Traditional chinese medicine for treating chronic gastritis and preparation method therefor | |
| KR100794445B1 (en) | Functional food composition for treating allergy, natural tee using the same and the manufacturing method thereof | |
| Brown et al. | “Legal Highs”–Constituents, Activity, Toxicology, and Herbal Folklore | |
| WO2004068974A1 (en) | A process of preparing a herbal filler composition for bidi cigarette and the like | |
| KR20050082663A (en) | Drink composition for mitigating the hangover containing the mixture of herbal extracts and method of manufacturing thereof | |
| WO1995023589A1 (en) | Clear non-alcoholic sinus and allergy medication | |
| KR20030062493A (en) | Powder of Cassia Tora L. and tea containing the same for treating constipation | |
| US20040137084A1 (en) | Treatment of allergic rhinitis | |
| JP2535311B2 (en) | Healthy tea containing bean as the main ingredient | |
| CN1164188C (en) | Hypoglycemic health-care tea and its preparing process | |
| JP3355471B2 (en) | Pain health tea and its production method | |
| JP2883889B2 (en) | Artemisia juice for health drink and method for producing the same | |
| KR20030084036A (en) | Boi tea compositions having anti-obesity and anti-hypercholesterolemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |